Form 4: Fortrea Holdings Inc. Director R. Andrew Eckert Acquires Restricted Stock Units

Director R. Andrew Eckert acquired 7,282 Restricted Stock Units (RSUs) of Fortrea Holdings Inc. on May 14, 2024, which vest in full one year later.

Summary

• On May 14, 2024, R. Andrew Eckert, a director of Fortrea Holdings Inc., acquired 7,282 Restricted Stock Units (RSUs).
• These RSUs will vest in their entirety on May 14, 2025, contingent upon Eckert's continued service as a director.
• Following this transaction, Eckert beneficially owns a total of 13,636 RSUs.
• The Form 4 filing was signed on May 16, 2024, by James Stillman Hanson, Attorney-in-Fact for R. Andrew Eckert.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director generally indicates confidence in the company's prospects, but it's a routine transaction.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance, but the RSU vesting is contingent on continued service as a director.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects standard practices for aligning management interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

• RSUs are a common form of equity compensation used across various industries to incentivize and retain key personnel.
• The vesting schedule of twelve months is fairly standard for RSU grants.
• Similar companies in the pharmaceutical and healthcare services sectors, such as IQVIA and Labcorp, also utilize RSUs as part of their executive compensation packages.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates